Prevention and detection of disease
Results
All (7)
All (7) ((7 results))
- 1. Canadians’ support for random COVID-19 testing ArchivedStats in brief: 45-28-0001202000100044Description:
Given the need for timely and accurate evidence of the impact of COVID-19 in the wider population, knowledge of Canadians’ attitudes toward a strategy of random COVID-19 testing is useful information for policy makers and public health officials. This study examines the extent to which crowdsourcing participants support random testing for COVID-19, with a focus on differences by sociodemographic characteristics as well as trust levels in governments and public health authorities.
Release date: 2020-08-25 - Stats in brief: 45-28-0001202000100072Description:
While access to COVID-19 testing has become more widely available, little is known about the extent to which Canadians intend to get tested for the virus and the reasons why they would request a test. This study aims to shed light on the reasons why Canadians would get tested for COVID-19 if testing were widely available and examines whether certain groups are more likely than others to indicate that they would get tested.
Release date: 2020-08-25 - 3. Canadians’ willingness to get a COVID-19 vaccine: Group differences and reasons for vaccine hesitancy ArchivedStats in brief: 45-28-0001202000100073Description:
The development of a COVID-19 vaccine has been identified as a key factor in ending the pandemic and returning to normal activities. Although a COVID-19 vaccine is not yet available, its success will ultimately depend on the proportion of the population who are willing to be vaccinated. This study examines Canadians’ willingness to get a COVID-19 vaccine, group differences and Canadians’ reasons for not intending to get a COVID-19 vaccine are examined.
Release date: 2020-08-25 - 4. Canadians’ willingness to get a COVID-19 vaccine when one becomes available: What role does trust play? ArchivedStats in brief: 45-28-0001202000100043Description:
The development of a COVID-19 vaccine has been identified as an important factor in reopening the economy and relaxing physical distancing measures imposed as a response to the pandemic. This study examines how crowdsourcing participants’ willingness to receive a COVID-19 vaccination when one becomes available differs by their level of trust in other people, government and public health authorities.
Release date: 2020-07-07 - Articles and reports: 82-003-X201500514169Description:
The Cancer Risk Management Model incorporates the risk of developing cancer, disease screening and clinical management with cost and labour data to assess health outcomes and economic impact. A screening module added to the lung cancer module enables a variety of scenarios to be evaluated for different target populations with varying rates of participation, compliance, and frequency of low-dose computed tomography screening.
Release date: 2015-05-20 - Articles and reports: 82-003-X201100311541Geography: Province or territoryDescription:
This report, based on the results of the Rapid Risk Factor Surveillance System survey, provides an overview of self-reported pH1N1 vaccination uptake for Ontario.
Release date: 2011-09-21 - Articles and reports: 11-522-X20020016722Geography: CanadaDescription:
Colorectal cancer (CRC) is the second cause of cancer deaths in Canada. Randomized controlled trials (RCT) have shown the efficacy of screening using faecal occult blood tests (FOBT). A comprehensive evaluation of the costs and consequences of CRC screening for the Canadian population is required before implementing such a program. This paper evaluates whether or not the CRC screening is cost-effective. The results of these simulations will be provided to the Canadian National Committee on Colorectal Cancer Screening to help formulate national policy recommendations for CRC screening.
Statistics Canada's Population Health Microsimulation Model was updated to incorporate a comprehensive CRC screening module based on Canadian data and RCT efficacy results. The module incorporated sensitivity and specificity of FOBT and colonoscopy, participation rates, incidence, staging, diagnostic and therapeutic options, disease progression, mortality and direct health care costs for different screening scenarios. Reproducing the mortality reduction observed in the Funen screening trial validated the model.
Release date: 2004-09-13
Data (0)
Data (0) (0 results)
No content available at this time.
Analysis (7)
Analysis (7) ((7 results))
- 1. Canadians’ support for random COVID-19 testing ArchivedStats in brief: 45-28-0001202000100044Description:
Given the need for timely and accurate evidence of the impact of COVID-19 in the wider population, knowledge of Canadians’ attitudes toward a strategy of random COVID-19 testing is useful information for policy makers and public health officials. This study examines the extent to which crowdsourcing participants support random testing for COVID-19, with a focus on differences by sociodemographic characteristics as well as trust levels in governments and public health authorities.
Release date: 2020-08-25 - Stats in brief: 45-28-0001202000100072Description:
While access to COVID-19 testing has become more widely available, little is known about the extent to which Canadians intend to get tested for the virus and the reasons why they would request a test. This study aims to shed light on the reasons why Canadians would get tested for COVID-19 if testing were widely available and examines whether certain groups are more likely than others to indicate that they would get tested.
Release date: 2020-08-25 - 3. Canadians’ willingness to get a COVID-19 vaccine: Group differences and reasons for vaccine hesitancy ArchivedStats in brief: 45-28-0001202000100073Description:
The development of a COVID-19 vaccine has been identified as a key factor in ending the pandemic and returning to normal activities. Although a COVID-19 vaccine is not yet available, its success will ultimately depend on the proportion of the population who are willing to be vaccinated. This study examines Canadians’ willingness to get a COVID-19 vaccine, group differences and Canadians’ reasons for not intending to get a COVID-19 vaccine are examined.
Release date: 2020-08-25 - 4. Canadians’ willingness to get a COVID-19 vaccine when one becomes available: What role does trust play? ArchivedStats in brief: 45-28-0001202000100043Description:
The development of a COVID-19 vaccine has been identified as an important factor in reopening the economy and relaxing physical distancing measures imposed as a response to the pandemic. This study examines how crowdsourcing participants’ willingness to receive a COVID-19 vaccination when one becomes available differs by their level of trust in other people, government and public health authorities.
Release date: 2020-07-07 - Articles and reports: 82-003-X201500514169Description:
The Cancer Risk Management Model incorporates the risk of developing cancer, disease screening and clinical management with cost and labour data to assess health outcomes and economic impact. A screening module added to the lung cancer module enables a variety of scenarios to be evaluated for different target populations with varying rates of participation, compliance, and frequency of low-dose computed tomography screening.
Release date: 2015-05-20 - Articles and reports: 82-003-X201100311541Geography: Province or territoryDescription:
This report, based on the results of the Rapid Risk Factor Surveillance System survey, provides an overview of self-reported pH1N1 vaccination uptake for Ontario.
Release date: 2011-09-21 - Articles and reports: 11-522-X20020016722Geography: CanadaDescription:
Colorectal cancer (CRC) is the second cause of cancer deaths in Canada. Randomized controlled trials (RCT) have shown the efficacy of screening using faecal occult blood tests (FOBT). A comprehensive evaluation of the costs and consequences of CRC screening for the Canadian population is required before implementing such a program. This paper evaluates whether or not the CRC screening is cost-effective. The results of these simulations will be provided to the Canadian National Committee on Colorectal Cancer Screening to help formulate national policy recommendations for CRC screening.
Statistics Canada's Population Health Microsimulation Model was updated to incorporate a comprehensive CRC screening module based on Canadian data and RCT efficacy results. The module incorporated sensitivity and specificity of FOBT and colonoscopy, participation rates, incidence, staging, diagnostic and therapeutic options, disease progression, mortality and direct health care costs for different screening scenarios. Reproducing the mortality reduction observed in the Funen screening trial validated the model.
Release date: 2004-09-13
Reference (0)
Reference (0) (0 results)
No content available at this time.
- Date modified: